Kindred Biosciences Analysis

Kindred Biosciences is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Kindred Biosciences delisted stock analysis is to determine its intrinsic value, which is an estimate of what Kindred Biosciences is worth, separate from its market price. There are two main types of Kindred Biosciences' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Kindred Biosciences' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Kindred Biosciences' stock to identify patterns and trends that may indicate its future price movements.
The Kindred Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Kindred Biosciences is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Kindred Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Kindred Biosciences' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

Kindred Stock Analysis Notes

About 19.0% of the company outstanding shares are owned by corporate insiders. The book value of Kindred Biosciences was now reported as 1.87. The company recorded a loss per share of 0.22. Kindred Biosciences had not issued any dividends in recent years. Kindred Biosciences, Inc., a commercial-stage biopharmaceutical company, engages in developing therapies for pets. The company was incorporated in 2012 and is headquartered in Burlingame, California. Kindred Biosciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 63 people. To find out more about Kindred Biosciences contact Richard Chin at (61) 8 9242 2227 or learn more at www.kinmining.com.au.

Kindred Biosciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Kindred Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Kindred Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Kindred Biosciences is not yet fully synchronised with the market data
Kindred Biosciences has some characteristics of a very speculative penny stock
Kindred Biosciences has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 5.78 M. Reported Net Loss for the year was (41.95 M) with loss before taxes, overhead, and interest of (1.16 M).
Kindred Biosciences has about 74.2 M in cash with (29.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.63.
Over 80.0% of the company shares are owned by institutional investors

Kindred Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 419.31 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kindred Biosciences's market, we take the total number of its shares issued and multiply it by Kindred Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Kindred Biosciences to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in Kindred Stock

If you are still planning to invest in Kindred Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kindred Biosciences' history and understand the potential risks before investing.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets